Member Login
  1. Stocks
    2. /
  2. OXB (LSE: OXB)
    3. /

LSE:OXB (OXB)

About OXB

OXB is a quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world. OXB, a FTSE4Good constituent, is headquartered in Oxford, UK. It has bioprocessing and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France and near Boston, MA, US.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • OXB (LSE: OXB) Latest News

    A senior man using hiking poles, on a hike on a coastal path along the coastline of Cornwall.
    Investing Articles

    3 under-the-radar UK shares that could make investors richer

    | Zaven Boyrazian, MSc (TMFBoyrazian)

    Motley Fool Share Advisor analyst Zaven Boyrazian outlines three hidden UK shares he’s investigating further for potential long-term returns.

    Read more »

    A row of satellite radars at night
    Top Stocks

    5 under-the-radar UK shares that deserve more attention

    | The Motley Fool Staff

    UK companies not widely covered may potentially offer a unique opportunity to buy shares in a future market winner.

    Read more »

    Engineer Project Manager Talks With Scientist working on Computer
    Investing Articles

    This skyrocketing growth stock is up 100% this year! Is it too late to buy?

    | Mark Hartley

    This small-cap stock has enjoyed spectacular growth this year, so I’m examining its prospects as it transitions to its new…

    Read more »

    Silhouette of a bull standing on top of a landscape with the sun setting behind it
    Investing Articles

    5 FTSE stocks Fools think will lead the next bull market charge

    | The Motley Fool Staff

    Savvy Fools will know the time to be buying the best FTSE stocks isn’t when a new bull market is…

    Read more »

    Genetic Techs with the text “Investing in Genetics Top UK Genetics Stocks in 2022” and The Motley Fool jester cap logo
    Page

    Investing in Genetics: Top UK Genetics Stocks of 2024

    | Zaven Boyrazian, MSc (TMFBoyrazian)

    Investing in genetics stocks is a risky endeavour. But given industry specialists have and continue to describe this space as…

    Read more »

    Engineer Project Manager Talks With Scientist working on Computer with the text “Investing in Biotech: Top UK Biotech Stocks in 2022” and The Motley Fool jester cap logo
    Page

    Investing in Biotech: Top UK Biotech Stocks of 2025

    | Zaven Boyrazian, MSc (TMFBoyrazian)

    Uncover the top UK biotech stocks & shares leading the charge in what could be a multi-trillion-dollar investment opportunity for…

    Read more »

    Investing Articles

    1 FTSE 250 stock to buy for long-term growth

    | Jabran Khan

    Jabran Khan explores a FTSE 250 stock he believes is primed to grow in the long term and explains why…

    Read more »

    Close-up of British bank notes
    Investing Articles

    1 UK stock I’d buy in 2022 to try to double my money

    | Zaven Boyrazian, MSc (TMFBoyrazian)

    With UK stocks on the rise in 2022, Zaven Boyrazian shares his top pick from his own portfolio that could…

    Read more »

    Investing Articles

    The Oxford Biomedica share price is up 80% in a year. Here’s what I’d do

    | Alan Oscroft

    The Oxford Biomedica (LON: OXB) share price has soared more than 600% in five years. Could there be be a…

    Read more »

    Investing Articles

    The Oxford BioMedica share price surges on earnings

    | Zaven Boyrazian, MSc (TMFBoyrazian)

    The Oxford BioMedica share price is on fire this month but can the upward momentum continue? Zaven Boyrazian explores its…

    Read more »

    Syringe and vial on blue background
    Investing Articles

    The Oxford Biomedica share price has doubled since signing its Covid-19 vaccine deal. Can the momentum continue?

    | Megan Boxall

    Oxford Biomedica’s share price is soaring. But is this simply the hype of its Covid-19 vaccine deal? Megan Boxall examines…

    Read more »

    Investing Articles

    Top British stocks for July

    | The Motley Fool Staff

    We asked our freelance writers to share their top British stocks for July, including Smith & Nephew, Motorpoint and TI…

    Read more »